بهترین پادکست های 340B (2024)

1
Ep 57 | Post-Election Outcome & 340B Implications 54:35

8h ago54:35

54:35

In this episode, Greg and Rob are joined by Rodney Whitlock, healthcare policy expert, to discuss the recent 2024 election results. They’ll discuss what the second Trump Administration might prioritize in terms of healthcare policy, how a Republican-controlled Congress will impact 340B legislation activity, and whether or not any developments comin…

1
How 340B Funds an Innovative Program for Cancer Survivors 20:50

3d ago20:50

20:50

The focus of attention on cancer care most often goes to the curative treatments required to put cancer into remission, but what do cancer survivors need after that point to fully recover and lead their best possible lives? We discuss that question and how 340B can help answer it with guests Sarah Loschiavo and Ellen Morris-White, two nurse practit…

1
Episode 4: Forecasting Election Impact on 340B, Plus Continued Battles Over Contract Pharmacies 22:19

10d ago22:19

22:19

Will Newton hosted this week’s episode, leading a discussion with Shannon Young and Bella Czajkowski. Ted Slafsky was away for this edition, but we look forward to welcoming him back next time. In this new episode, the editorial team explores emerging trends in drugmaker contract pharmacy restrictions, legal developments around 340B eligibility cal…

1
Ep 56 | 2024 General Election Outlook & 340B 55:47

17d ago55:47

55:47

In this episode, Greg and Rob are joined by Mike Strazzella, government affairs expert from Buchanan Ingersoll & Rooney, to discuss the upcoming general election, and what races may be critical to future 340B policy developments. They’ll discuss Senate and House races that could precipitate leadership changes in Congressional committees that drive …

1
How 340B Is All About Health Equity 22:41

17d ago22:41

22:41

The 340B drug pricing program is crucial for safety-net hospitals and other providers that care for patients in need, especially those whom traditionally have been underserved by the broader health system. We speak with Dr. Tony Jackson, assistant vice president for pharmacy services at Scripps Health in San Diego, for his views on why 340B is “all…

1
Episode 3: The 340B Rebate Saga: Fallout and Potential Litigation 21:04

24d ago21:04

21:04

Episode 3: The 340B Rebate Saga: Fallout and Potential Litigation Shannon Young, Will Newton and Bella Czajkowski, explore the biggest developments in the 340B program, focusing on the latest surrounding Johnson & Johnson’s (J&J) rebate proposal, including the potential for litigation. They also recap key discussions from a recent healthcare summit…

1
How Hospitals Won This Round in the 340B Rebate Fight 18:19

1M ago18:19

18:19

Within the past few weeks, drugmaker Johnson & Johnson went head-to-head with 340B hospitals and the federal government over the company’s plan to stop paying upfront 340B discounts on two of its top-selling drugs. 340B Health Senior Counsel Amanda Nagrotsky joins us to explain how that conflict played out. HRSA Warns Johnson & Johnson of Strong Pu…

1
Ep 55 | All About 340B Modifiers 58:43

1M ago58:43

58:43

In this episode, Greg and Rob discuss the various uses of 340B billing modifiers. They’ll discuss some general considerations around what billing modifiers are used for, highlight differences between hospital/clinic and pharmacy billing in terms of applying correct modifiers, and debate different aspects of Medicaid and Medicare billing modifier re…

1
Episode 2: HRSA Responds to J&J’s Rebate Proposal; Capitol Hill Inquiries; State-Level Battles 31:08

1M ago31:08

31:08

In episode 2, host Ted Slafsky, along with Will Newton and Bella Czajkowski, recap major news impacting the 340B program, including the future of manufacturer efforts to convert 340B to a rebate, Sen. Bill Cassidy’s latest inquiry into two drugmakers, pushback from bipartisan House members to the rebate proposal federal 340B legislation and key sta…

1
Ep 54 | 340B Operations Discussion – “Clean Site” Locations 50:19

1M ago50:19

50:19

In this episode, Greg and Rob get back to 340B basics and have a conversation around the concept of “clean site” 340B-only locations. They discuss what “clean site” means in the world of 340B, what the benefits of the approach are, what some of the risks and obstacles are from a compliance perspective, and share some anecdotes from past experiences…

1
The Latest on 340B Rebates 21:39

2M ago21:39

21:39

A renewed push by a drugmaker to fundamentally transform 340B has the potential to cause major problems for 340B hospitals if allowed to take effect. 340B Health President and CEO Maureen Testoni joins us to explain the controversial 340B rebate issue and to cover some of the other recent developments in the 340B world. A Plan To Replace Upfront Di…

1
Ep 53 | J&J 340B Rebate Model Follow-Up Discussion 52:59

2M ago52:59

52:59

In this episode, Greg and Rob catch up on developments surrounding the J&J 340B rebate proposal, including HRSA’s response. They’ll address some outstanding questions from the recent SpendMend webinar on the topic. In the intro, they recap some updates regarding contract pharmacy litigation and thoughts on how DSCSA and product serialization data m…

1
Introducing the Inside 340B Report Editorial Team 20:48

2M ago20:48

20:48

Episode 1: Introducing the Inside 340B Report Editorial Team Welcome to the very first episode of the Inside 340B Report podcast! In this debut episode, host Ted Slafsky, publisher and CEO of 340B Report, introduces listeners to the dynamic editorial team behind the show, Shannon Young, Will Newton, and Bella Czajkowski, as they share their backgro…

1
How a 340B Direct Savings Plan Works for Hospitals 15:18

2M ago15:18

15:18

The 340B drug pricing program is designed to give hospitals the flexibility to use their savings toward the types of patient care and support that their communities need the most. How does that work for hospitals that decide to use their access to 340B to provide the discounts directly to patients who cannot afford their drugs? Paul Orth, 340B prog…

1
Inside 340B Report Trailer 2:08

2M ago2:08

2:08

Inside 340B Report is your exclusive, behind-the-scenes window into the latest news and developments in the 340B drug pricing program, straight from the journalists at 340B Report. Each episode, published twice a month, brings listeners inside 340B Report’s newsroom for a candid, insider’s perspective on the evolving drug pricing policy landscape f…

1
Ep 52 | 340B Smorgasbord - Contract Pharmacy Legislation, ADR, Section 1115 Waiver Days & 340B Rebate Models 1:15:32

2M ago1:15:32

1:15:32

In this episode, Greg and Rob are joined by healthcare attorney and 340B veteran Barbara Straub Williams. They cover a variety of topics, including an update on litigation targeting state-level contract pharmacy laws (21:18), navigating manufacturer audits and ADR claim submissions (38:47), a recent court ruling related to exclusion of Section 1115…

1
Benefits of auditing every NDC and dispense every month 4:11

3M ago4:11

4:11

توسط Stuart Murray

1
Ep 51 | CMS Medicaid Drug Rebate Program & “Covered Outpatient Drug” Definition 1:17:32

3M ago1:17:32

1:17:32

In this episode, Greg and Rob are joined by healthcare attorney Todd Nova to discuss a proposed rule change put forth by CMS in 2023 regarding the Medicaid Drug Rebate Program (MDRP), which includes a potential change to the definition of “covered outpatient drug”. They’ll discuss how covered entities have historically interpreted the definition of…

1
How Must Hospitals Recertify Their 340B Eligibility? 17:26

3M ago17:26

17:26

This marks the time of year when 340B hospitals complete the recertification process to maintain their eligibility for 340B. But why is this recertification needed, and what do hospitals need to know before undergoing recertification? Steven Miller, the vice president of pharmacy services for 340B Health, describes what is at stake when it comes to…

1
Interview with Optimal 340B: Navigating the Complexities Operational Challenges in the 340B Program 7:48

3M ago7:48

7:48

This is an interview with Lyssa Limbrecht-Moss, founder and CEO or Optimal 340B, on the complexities and operational challenges in the 340B program.توسط Stuart Murray and Lyssa Limbrecht-Moss

1
Tips on finding bad multipliers 2:57

3M ago2:57

2:57

Short episode on how to use your TPA web portal to find bad multipliers (conversion factors).توسط Stuart Murray

1
Ep 50 | 340B Q&A with Hoopii 46:34

3M ago46:34

46:34

This is our 50th episode, and it marks the 2 year anniversary of the 340B Unscripted Podcast. To mark the occasion, Greg asks Rob a hodgepodge of 340B-related questions including entity-owned vs contract pharmacy considerations, out-of-state Medicaid carve-out challenges, “class of trade”, referral capture documentation standards and how CEs should…

1
Quickly recover lost savings 2:34

3M ago2:34

2:34

Learn how to quickly recover thousands of dollars, even hundreds of thousands, in lost savings!توسط Stuart Murray

1
What Role Can AI Play in 340B? 15:46

3M ago15:46

15:46

Artificial intelligence is a hot topic in 2024. Discussions about AI in health care continue to grow, including about the potential for such technology to improve care and save lives. What role might AI play in the 340B world? We speak with WVU Medicine Enterprise 340B Program Coordinator Elizabeth Gibson to learn how one health system is exploring…

1
Unveiling UW Medicine's 340B Impact: A Conversation with Sumona Das Gupta 14:17

4M ago14:17

14:17

In this episode of the 340B Insider podcast, Sumona discusses UW Medicine's new initiative to highlight the impact of the 340B program and share the multifaceted benefits of 340B in enhancing patient care and community health. She explains how the initiative was structured, the role of the 340B oversight committee, and the importance of creating a …

1
What Are the Keys To Enacting State 340B Protections? 20:49

4M ago20:49

20:49

We have released several episodes in recent months in which we have discussed federal and state legislative efforts on 340B. But what does it take to get 340B protections through a state legislature and to the governor’s desk? In this episode, we speak with Ryan Cross, vice president of governmental affairs with Franciscan Missionaries of Our Lady …

1
Ep 49 | HRSA Audit Trends and Manufacturer Audit Activity – Conversation with Emily Cook 1:05:53

4M ago1:05:53

1:05:53

In this episode, Greg and Rob have another repeat guest! Healthcare attorney Emily Cook shares some insights gained from the 340B Coalition Summer Conference around recent HRSA audit patterns (08:37) and a cluster of manufacturer audits of 340B covered entities (27:46). In the intro, the guys touch base on some 340B newsworthy developments in the c…

1
States Make Big Moves With 340B Policy 16:49

4M ago16:49

16:49

While significant 340B actions have happened at the federal level, state legislatures also have made big moves in the world of 340B so far this year. We are joined by Amanda Sellers Smith, 340B Health’s legal counsel, to explain more. More states ban drug company restrictions on 340B contract pharmacies Following the lead of Arkansas and Louisiana,…

1
Ep 48 | 2024 Midyear 340B Review - Conversation with Ted Slafsky 1:14:37

4M ago1:14:37

1:14:37

In this episode, Greg and Rob gear up for the 340B Summer Coalition conference, and are joined again by Ted Slafsky to discuss various 340B developments from the first half of 2024. They’ll discuss the ongoing contract pharmacy saga between entities and manufacturers, debate the future of proposed federal legislation addressing 340B Program reform,…

1
A Key Federal Court Ruling on 340B 20:46

5M ago20:46

20:46

The world of 340B has seen significant developments on the state and national levels in recent months. A second federal appeals court decision on 340B contract pharmacies came down in recent weeks, a new bill in Congress threatens to impose significant restrictions on hospital participation in 340B program, and more states move to protect covered e…

1
Ep 47 | Alternate Distribution Models & 340B 55:07

5M ago55:07

55:07

In this episode, Greg and Rob are joined by a new SpendMend team member – Nick Gnadt – to discuss considerations around the use of alternate distribution models (ADMs) in the 340B space. They discuss some of the practical considerations around implementing ADM, where there may be operational or regulatory challenges, and what the long-term outlook …

1
How To Navigate the 340B ADR Process 21:29

5M ago21:29

21:29

The finalized 340B administrative dispute resolution (ADR) rule is set to go into effect on June 18 and will create a process to settle certain disputes between covered entities and drug manufacturers. But what should covered entities know about this process before it launches? Jason Reddish, a 340B expert with the Powers Pyles Sutter & Verville he…

1
Ep 46 | Revisiting the Intersection of the IRA Medicare Drug Pricing Program & 340B – Conversation with Jeff Davis 53:12

5M ago53:12

53:12

In this episode, Greg and Rob welcome back health care attorney Jeff Davis to catch up on the latest draft guidance published by CMS to address IRA-mandated Medicare drug pricing provisions and impact to 340B providers (15:25). Additionally, they chat about the 340B ACCESS Act, a new piece of draft legislation introduced in the House with sweeping …

1
Ep 45 | Chevron Doctrine & 340B 54:01

6M ago54:01

54:01

In this episode, Greg and Rob are joined by healthcare attorney Ross Marguiles to discuss how a Supreme Court ruling on litigation in the fishing industry could have a major impact on the healthcare landscape. Ross provides background on Chevron deference, a 40-year judicial doctrine that allows courts to defer ruling to federal administrative agen…

1
How 340B Savings Can Help Hospitals Take Their Care on the Road 21:53

6M ago21:53

21:53

Hospitals throughout the U.S. use their 340B savings in innovative ways to care for their patients in need. In some cases, they can take that care outside the walls of the hospital to meet patients where they learn, live, and play. We speak with Heather Armstrong with Comanche County Medical Center in central Texas to tell us how her health system …

1
Ep 44 | Pharmacotherapy Clinic Services & 340B 53:22

6M ago53:22

53:22

In this episode, SpendMend colleague Matt Parker joins Greg and Rob (14:00) to discuss pharmacotherapy services, and how pharmacist-driven care can help promote improved health outcomes in a community, as well as how these services might intersect with a covered entity’s 340B Program. They highlight the clinical and financial benefits that these se…

1
The Potential of 340B Optimization 19:41

7M ago19:41

19:41

340B savings can help hospitals and other covered entities better serve patients and improve their health outcomes. But how can these entities make the best use of 340B funds for their institutions? We sat down with Matt Webber, director of pharmacy business at Novant Health based in North Carolina, to learn more. 340B optimization strategies One w…

1
Ep 43 | Getting to Know the HRSA DRL – DRL 8 Self-Disclosure Documentation and DRL 9 Medicaid Billing Information 51:10

7M ago51:10

51:10

In this episode, Greg and Rob continue to provide insights on the HRSA data request list. DRL #8 is self-disclosure documentation and DRL #9 is Medicaid billing information, which includes providing details regarding your CE’s listing on the Medicaid Exclusion File, as well as sample billing claim forms for physician-administered drugs and billing …

1
New Federal and State Legislative Movement on 340B 21:51

7M ago21:51

21:51

The 340B community has seen major activity on several fronts since the start of 2024 – the introduction of new legislation on Capitol Hill, movement on legislation in the states, and key developments in the courts. 340B Health President and CEO Maureen Testoni returns to the show to help us make sense of these developments and how they might affect…

1
Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 2 44:43

7M ago44:43

44:43

SpendMend colleagues Jasmine and Megan continue their conversation providing some grantee CE perspectives concerning the HRSA DRL.توسط SpendMend Pharmacy

1
Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 1 48:48

7M ago48:48

48:48

In this episode, SpendMend colleagues Jasmine and Megan provide some grantee CE perspectives concerning the HRSA DRL. They have so much great insight, we are breaking this conversation up into two parts. Stay tuned for Part 2 next week! In the intro, Rob and Greg discuss thoughts around responding to manufacturer 340B inquiries.…

1
How To Prevent 340B Duplicate Discounts 22:34

8M ago22:34

22:34

One of the most important elements of 340B compliance is preventing duplicate discounts. Ensuring there are no duplicate discounts is high on the list of compliance concerns for covered entities, and it is one of the major items that 340B auditors look for. But how do these entities ensure they stay compliant? On this episode, we speak to Melissa B…

1
Ep 41 | 340B News & Notes 29:14

8M ago29:14

29:14

In this episode, Rob and Greg catch up on a cluster of developments in the 340B space, including updates to manufacturer contract pharmacy restrictions, thoughts on a federal appellate court ruling on Arkansas' contract pharmacy law, a preliminary take on the 340B PATIENTS Act recently introduced by Rep. Doris Matsui (D-CA), and an update on ongoin…

1
Exploring the Legal and Legislative Landscape of 340B with Ted Slafsky 23:47

8M ago23:47

23:47

In this podcast episode, we are joined by Ted Slafsky, Publisher and CEO of the 340B Report and Founder & Principal of Wexford Solutions LLC. During our discussion, Ted highlights ongoing federal court decisions and updates listeners on states like Arkansas and Louisiana, where laws restoring 340B pricing have faced legal challenges but are making …

1
How Do 340B Child Site Eligibility Changes Affect Hospitals? 16:29

8M ago16:29

16:29

340B hospitals can register certain outpatient locations with the Health Resources & Services Administration (HRSA) as 340B child sites, which allows them to use 340B drugs. HRSA recently announced some changes to how it had been determining this eligibility during the COVID-19 public health emergency. How have these changes affected 340B hospitals…

1
Ep 40 | Getting to Know the HRSA DRL: DRL 5 Purchasing Documentation and DRL 7 Entity-Owned Pharmacy Documentation 48:20

8M ago48:20

48:20

In this episode, Greg and Rob continue reviewing data solicited by HRSA during an audit. DRL #5 is purchasing documentation, including a list of accounts, sample invoices, and 340B purchase order details. This ends up being a labor-intensive section to complete for HRSA, especially for larger organizations with a variety of purchasing practices. DR…

1
How To Get Through a 340B Audit 16:15

9M ago16:15

16:15

The Health Resources & Services Administration audits 200 covered entities each year for compliance with 340B rules. We speak with Mark Capuano, senior director of the corporate pharmacy 340B program at New York City Health and Hospitals, about what hospitals should expect when they find out they will be going through a 340B audit. How a hospital c…

1
Ep 39 | A Revisit of Ongoing Contract Pharmacy Restrictions 32:39

9M ago32:39

32:39

In this episode, Greg and Rob are once again joined by SpendMend team member Riley Protz, to catch up on the current state of ongoing manufacturer restrictions on 340B contract pharmacy operations, as well as to offer insights on various mitigation strategies, like the opportunity for grantee CEs to make associated site contract pharmacy designatio…

1
How New 340B Reporting Requirements Are Affecting Hospitals 17:40

9M ago17:40

17:40

340B sits at an intersection where federal programs and state agencies come together. Maine, Minnesota, and Washington recently enacted new laws requiring hospitals to report 340B information to the states each year. What should health systems know about these new requirements? We speak with Danny Ackert, the director of state government relations …

1
Ep 38 | Getting to Know the HRSA DRL: DRL 4 Provider List and DRL 6 Contract Pharmacy Documentation 1:04:50

9M ago1:04:50

1:04:50

In this episode, Greg and Rob continue their review of items from the HRSA audit data request list (DRL). They’ll cover DRL #4, the provider list, as well as DRL #6, contract pharmacy documentation. Don’t worry – they’ll come back to DRL #5 (purchasing documentation) in an upcoming episode! In the intro, Rob shares a few insights from the recent 34…

پادکست هایی که ارزش شنیدن دارند

پادکست های 340B

پادکست هایی که ارزش شنیدن دارند

راهنمای مرجع سریع